University of Alabama at Birmingham
Birmingham, Alabama, 35205, United States
NCT Number: NCT00711815
This is a research study looking at gene characteristics in blood and Pap smear samples in hopes of identifying markers that will predict if the HPV infection is present or not.
Looking for future studies?
Notify Me19 year and older
Female
Observational
Birmingham, Alabama, 35205, United States
Because infection with high-risk human papillomavirus is a necessary cause of cervical cancer, HPV testing has many potential uses in cervical cancer screening. Unfortunately, like cytology, it suffers from a lack of specificity when used for population-based screening. Given that HPV testing detects more cases of CIN3+ than cytology and that it would probably be more practical in developing regions, finding a biomarker that would increase specificity has been the goal for much research on HPV and cervical cancer. The goal of this study is to explore potential predictors of viral clearance, specifically RNA levels of candidate genes in cervical swabs and host genetic polymorphisms, in the context of genotype-specific infection data.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Alabama at Birmingham
Other
Biomarkers of HPV Clearance: A Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07244315
Cervical Cancer Screening, Cervical Intraepithelial Neoplasia
Bafoussam, Cameroon
View Trial DetailsNCT07081334
Communicable Diseases, DNA Virus Infections
Seoul, South Korea
View Trial DetailsNCT05372016
AIS, CIN1
Guangxi, China
View Trial DetailsNCT00682812
Communicable Diseases, DNA Virus Infections
Marseille, France
View Trial Details